A peer-reviewed paper from Regenyx Medical and its collaborators at Ben-Gurion University and Tel Aviv Medical Center has been published in Aesthetic Surgery Journal Open Forum. In the preclinical study, the company’s novel synthetic peptide hydrogel improved adipocyte viability and reduced inflammatory response in fat grafting, an important validation of the science behind Regenyx’s matrix-graft platform as it advances Lipogenyx toward clinical testing.
Peptide hydrogel enhances adipocyte viability and reduces inflammatory response in fat grafting: A preclinical study featuring Regenyx Medical
